Effects of bone cement extracts on the cell-mediated immune response

Donatella Granchi, Gabriela Ciapetti, Lucia Savarino, Elisabetta Cenni, Arturo Pizzoferrato, Nicola Baldini, Armando Giunti

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The aim of the study was to evaluate some aspects of the immunocompatibility of 10 acrylic bone cements. Mononuclear cells harvested from healthy individuals were cultured with cement extracts which were tested to assess their effect on the viability of lymphocytes, unstimulated and phytohaemoagglutinin (PHA)-stimulated, activating resting lymphocytes, and changing the reactivity of PHA-stimulated lymphocytes. After 24h the extracts did not increase the percentage of dead cells in unstimulated or PHA-stimulated lymphocytes. The early apoptotic events of culture were evaluated after 4 and 24h in PHA-stimulated lymphocytes: at 4h three cements, namely Zimmer-dough type, Palacos®R and CMW-1, increased significantly the percentage of apoptotic cells, while at 24h no differences were found. Cement extracts did not activate the resting lymphocytes, whereas the response of the PHA-stimulated cells was significantly modified. All cements decreased the expression of the interleukin 2 receptor (CD25) and the lymphocyte proliferation, whereas only two materials (Zimmer-dough type, CMW 1) affected the expression of early activation antigen (CD69). These findings show that the products released from bone cement are not able, by themselves, to elicit a specific immune response; on the contrary they hamper the function of lymphocytes activated by an exogenous stimulus.

Original languageEnglish
Pages (from-to)1033-1041
Number of pages9
JournalBiomaterials
Volume23
Issue number4
DOIs
Publication statusPublished - Feb 15 2002

Fingerprint

Bone cement
Bone Cements
Lymphocytes
Cell Extracts
Phytohemagglutinins
Cements
Histocompatibility
Interleukin-2 Receptors
Polymethyl Methacrylate
Antigens
Cell culture
Acrylics
Chemical activation
Cells

Keywords

  • Bone cement
  • Immune depression
  • Immune response
  • Lymphocyte activation

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering

Cite this

Effects of bone cement extracts on the cell-mediated immune response. / Granchi, Donatella; Ciapetti, Gabriela; Savarino, Lucia; Cenni, Elisabetta; Pizzoferrato, Arturo; Baldini, Nicola; Giunti, Armando.

In: Biomaterials, Vol. 23, No. 4, 15.02.2002, p. 1033-1041.

Research output: Contribution to journalArticle

Granchi, Donatella ; Ciapetti, Gabriela ; Savarino, Lucia ; Cenni, Elisabetta ; Pizzoferrato, Arturo ; Baldini, Nicola ; Giunti, Armando. / Effects of bone cement extracts on the cell-mediated immune response. In: Biomaterials. 2002 ; Vol. 23, No. 4. pp. 1033-1041.
@article{05e924822f1648ea87d398975fb64cfd,
title = "Effects of bone cement extracts on the cell-mediated immune response",
abstract = "The aim of the study was to evaluate some aspects of the immunocompatibility of 10 acrylic bone cements. Mononuclear cells harvested from healthy individuals were cultured with cement extracts which were tested to assess their effect on the viability of lymphocytes, unstimulated and phytohaemoagglutinin (PHA)-stimulated, activating resting lymphocytes, and changing the reactivity of PHA-stimulated lymphocytes. After 24h the extracts did not increase the percentage of dead cells in unstimulated or PHA-stimulated lymphocytes. The early apoptotic events of culture were evaluated after 4 and 24h in PHA-stimulated lymphocytes: at 4h three cements, namely Zimmer-dough type, Palacos{\circledR}R and CMW-1, increased significantly the percentage of apoptotic cells, while at 24h no differences were found. Cement extracts did not activate the resting lymphocytes, whereas the response of the PHA-stimulated cells was significantly modified. All cements decreased the expression of the interleukin 2 receptor (CD25) and the lymphocyte proliferation, whereas only two materials (Zimmer-dough type, CMW 1) affected the expression of early activation antigen (CD69). These findings show that the products released from bone cement are not able, by themselves, to elicit a specific immune response; on the contrary they hamper the function of lymphocytes activated by an exogenous stimulus.",
keywords = "Bone cement, Immune depression, Immune response, Lymphocyte activation",
author = "Donatella Granchi and Gabriela Ciapetti and Lucia Savarino and Elisabetta Cenni and Arturo Pizzoferrato and Nicola Baldini and Armando Giunti",
year = "2002",
month = "2",
day = "15",
doi = "10.1016/S0142-9612(01)00215-0",
language = "English",
volume = "23",
pages = "1033--1041",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - Effects of bone cement extracts on the cell-mediated immune response

AU - Granchi, Donatella

AU - Ciapetti, Gabriela

AU - Savarino, Lucia

AU - Cenni, Elisabetta

AU - Pizzoferrato, Arturo

AU - Baldini, Nicola

AU - Giunti, Armando

PY - 2002/2/15

Y1 - 2002/2/15

N2 - The aim of the study was to evaluate some aspects of the immunocompatibility of 10 acrylic bone cements. Mononuclear cells harvested from healthy individuals were cultured with cement extracts which were tested to assess their effect on the viability of lymphocytes, unstimulated and phytohaemoagglutinin (PHA)-stimulated, activating resting lymphocytes, and changing the reactivity of PHA-stimulated lymphocytes. After 24h the extracts did not increase the percentage of dead cells in unstimulated or PHA-stimulated lymphocytes. The early apoptotic events of culture were evaluated after 4 and 24h in PHA-stimulated lymphocytes: at 4h three cements, namely Zimmer-dough type, Palacos®R and CMW-1, increased significantly the percentage of apoptotic cells, while at 24h no differences were found. Cement extracts did not activate the resting lymphocytes, whereas the response of the PHA-stimulated cells was significantly modified. All cements decreased the expression of the interleukin 2 receptor (CD25) and the lymphocyte proliferation, whereas only two materials (Zimmer-dough type, CMW 1) affected the expression of early activation antigen (CD69). These findings show that the products released from bone cement are not able, by themselves, to elicit a specific immune response; on the contrary they hamper the function of lymphocytes activated by an exogenous stimulus.

AB - The aim of the study was to evaluate some aspects of the immunocompatibility of 10 acrylic bone cements. Mononuclear cells harvested from healthy individuals were cultured with cement extracts which were tested to assess their effect on the viability of lymphocytes, unstimulated and phytohaemoagglutinin (PHA)-stimulated, activating resting lymphocytes, and changing the reactivity of PHA-stimulated lymphocytes. After 24h the extracts did not increase the percentage of dead cells in unstimulated or PHA-stimulated lymphocytes. The early apoptotic events of culture were evaluated after 4 and 24h in PHA-stimulated lymphocytes: at 4h three cements, namely Zimmer-dough type, Palacos®R and CMW-1, increased significantly the percentage of apoptotic cells, while at 24h no differences were found. Cement extracts did not activate the resting lymphocytes, whereas the response of the PHA-stimulated cells was significantly modified. All cements decreased the expression of the interleukin 2 receptor (CD25) and the lymphocyte proliferation, whereas only two materials (Zimmer-dough type, CMW 1) affected the expression of early activation antigen (CD69). These findings show that the products released from bone cement are not able, by themselves, to elicit a specific immune response; on the contrary they hamper the function of lymphocytes activated by an exogenous stimulus.

KW - Bone cement

KW - Immune depression

KW - Immune response

KW - Lymphocyte activation

UR - http://www.scopus.com/inward/record.url?scp=0037082745&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037082745&partnerID=8YFLogxK

U2 - 10.1016/S0142-9612(01)00215-0

DO - 10.1016/S0142-9612(01)00215-0

M3 - Article

C2 - 11791906

AN - SCOPUS:0037082745

VL - 23

SP - 1033

EP - 1041

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 4

ER -